Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.

Source:http://linkedlifedata.com/resource/pubmed/id/19201859

J. Immunol. 2009 Feb 15 182 4 2063-73

Download in:

View as

General Info

PMID
19201859